We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variet... Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in most breast cancers at low, intermediate, and high or overexpressor levels. Show more
STAFFORD, Texas, March 13, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical...
STAFFORD, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical...
STAFFORD, Texas, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical...
STAFFORD, Texas, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.25 | -1.96078431373 | 12.75 | 13.38 | 11.375 | 39896 | 12.61206265 | CS |
4 | -7.93 | -38.8154674498 | 20.43 | 20.43 | 11.375 | 37697 | 15.08119295 | CS |
12 | 3.62 | 40.7657657658 | 8.88 | 21.44 | 8 | 54698 | 14.47204668 | CS |
26 | 4.62 | 58.6294416244 | 7.88 | 21.44 | 7.58 | 35002 | 13.28363514 | CS |
52 | 1.63 | 14.995400184 | 10.87 | 21.44 | 7.58 | 26551 | 12.18088227 | CS |
156 | -23.06 | -64.848143982 | 35.56 | 48.96 | 6.8241 | 70461 | 18.38686662 | CS |
260 | 7.5 | 150 | 5 | 158.07 | 3.262 | 162936 | 36.96356867 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions